Gemphire Therapeutics Inc.
Gemphire Therapeutics Inc. (GEMP) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 46 transactions totaling $8.2M, demonstrating a bullish sentiment with $8.2M in net insider flow. The most recent transaction on Jul 24, 2019 involved a transaction of 300,000 shares valued at $0.
GEMP Insider Activity Summary
Who Is Buying GEMP Stock?
No significant insider buying has been recorded for GEMP in the recent period.
Who Is Selling GEMP Stock?
No significant insider selling has been recorded for GEMP in the recent period.
Is Gemphire Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for GEMP is bullish with an Insider Alignment Score of 100/100 and a net flow of $8.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
GEMP Frequently Asked Questions
Understanding GEMP Insider Activity
Insider trading at Gemphire Therapeutics Inc. (GEMP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading GEMP stock, having executed 46 transactions in the past 90 days. The most active insider is Steven R. Ph.d. Gullans (Executive), who has made 5 transactions totaling $8.1M.
Related Tools
Track Gemphire Therapeutics Inc. Insider Activity
Get notified when executives and directors at GEMP file new Form 4 transactions